The rise in difficult-to-treat super bugs spread from skin-to-skin contact stresses the need for thermometers that do not touch the patient
DELRAY BEACH, Fla., June 11, 2018 (GLOBE NEWSWIRE) — PositiveID Corporation (“PositiveID” or “Company”) (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Thermomedics subsidiary will exhibit the Caregiver® non-contact thermometer at the Association for Professionals in Infection Control and Epidemiology (APIC) 2018 Annual Conference from June 13-15th at the Minneapolis Convention Center in Minneapolis, MN.
Caregiver, FDA cleared for clinical use, is a professional grade, infrared thermometer that measures forehead temperature in adults, children, and infants, without contact. It delivers an oral-equivalent temperature directly from the forehead in one to two seconds without ever touching the patient.
Infectious diseases like Ebola, Candida Auris, and others that can be spread from skin-to-skin contact stress the need to utilize thermometers and other medical devices that do not touch the patient thereby minimizing cross-contamination.
Since Caregiver does not touch the patient’s skin, it reduces the risk of cross-contamination and saves healthcare facilities the cost of probe covers (up to $0.10 per temperature), storage space, and waste disposal costs. It is estimated that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone. Caregiver is available with and without Bluetooth® functionality.
APIC’s Annual Conference is the premier forum for infection prevention and epidemiology professionals who want to learn about the latest research, science, and real-world solutions to challenging infection prevention issues. PositiveID’s Thermomedics team is exhibiting at the APIC conference to increase exposure and awareness for Caregiver and generate qualified leads for its national network of distributors.
APIC is a nonprofit, professional association comprised of more than 15,000 members whose responsibility is the prevention and control of infections and related adverse outcomes in patients and healthcare workers. APIC promotes wellness and prevents illness and infection worldwide by advancing healthcare epidemiology through education, research, collaboration, practice guidance, and credentialing. APIC’s mission is to create a safer world through the prevention of infection.
About PositiveID Corporation
PositiveID Corporation is a holding company with a focus on life sciences tools and diagnostics. PositiveID’s ExcitePCR subsidiary develops biological detection and diagnostics systems, specializing in the development of microfluidic systems for the automated preparation of and performance of biological assays. PositiveID’s Thermomedics subsidiary markets the FDA-cleared Caregiver® non-contact infrared thermometer. PositiveID also owns a minority interest in E-N-G Mobile Systems, a leader in the specialty vehicle market. For more information on PositiveID, please visit http://www.psidcorp.com, or connect with PositiveID on Twitter, Facebook or LinkedIn.
Statements about PositiveID’s future expectations, including the likelihood that Caregiver can offer savings of $250 or more per year per device in probe cover supplies alone; constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. These risks and uncertainties include, without limitation, the Company’s ability to raise capital; the Company’s ability to target the professional healthcare market; as well as other risks. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on April 2, 2018, and 10-Qs filed on May 18, 2018, November 13, 2017, and August 14, 2017, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
CONTACT: Contact: PositiveID Corporation Allison Tomek (561) 805-8044 email@example.com